Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in São Paulo, Brazil
Introduction
Human immunodeficiency virus-1 (HIV-1) is the causative agent of AIDS and can persist in individuals for years before causing disease. The HIV-1 genome is approximately 9.5 kb and displays significant sequence variations as a result of constant mutation and evolutionary pressure. Based on these genetic variations and pattern observed in phylogenetic reconstruction, researchers have classified the virus into groups, subtypes and sub-subtypes (Robertson et al., 2000). Currently, three groups (M, main; O, outlier; N, neither) have so far been recognized. HIV-1 group M viruses are responsible for the current global epidemic and are further classified into nine (A–D, F–H, J and K) subtypes, approximately equidistant, although subtypes B and D seem to be more closely related. Moreover, early sequencing studies have provided evidence of interstrand crossovers between genomes of different HIV subtypes (Sabino et al., 1994, Robertson et al., 1995). Such interclade recombinant strains are consistently reported from regions where two or more clades are predominant. Recombinant strains from unlinked epidemiological sources that exhibit identical patterns of mosaicism have been classified separately as circulating recombinant forms (CRFs) (Carr et al., 1998). There are currently 16 defined CRFs, namely CRF01–CRF16 and are epidemiologically important as subtypes. HIV-1 subtypes and CRFs show considerably different patterns of distribution in different geographical regions.
In South America, HIV epidemic is concentrated among people at increased risk of infection like injecting drug users, and men who have sex with men. The most prevalent HIV genetic subtypes are subtypes B, BF recombinants and F (Hierholzer et al., 2002). CRF12_BF and its related recombinant forms are widely circulating in Argentina (Carr et al., 2001, Thomson et al., 2002).
Brazil is the Latin American country that has been hardest hit by the HIV epidemic and has the second highest number of HIV-1 cases in the Americas, after the USA with an estimated number of 610,000 HIV-1/AIDS cases at the end of 2001 (Global AIDS program, 2004). HIV-1 subtype B is a major genetic form circulating in the country, however, existence of small proportion of other subtypes such as F, C, B/C and B/F have been consistently reported (Sabino et al., 1994, Cornelissen et al., 1996, Bongertz et al., 2000, Caride et al., 2000, Brindeiro et al., 1999). Typing strategies of these strains are based on sequencing of one or multiple short fragments of the viral genome, which may not accurately define the true HIV-1 genetic structure. Efforts to search for CRFs in Brazil in two recent studies did not find a common ancestry of Brazilian recombinants or their relationship to CRF12_BF (Thomson et al., 2004, Sa Filho et al., 2005). The current study was undertaken to characterize HIV-1 near full-length genomes from patients previously assigned as infected with non-recombinant HIV-1 subtypes B and F1 variants based on small portion of viral genome.
Section snippets
Samples
A total of 14 HIV-1 strains isolated from adult Brazilian patients attending HIV/AIDS treatment centre were selected as representative of pure subtype B or F1 variants based on small portion of their genome. These isolates were genotyped in our laboratory by sequencing part of pol region to determine their genotypic resistance to antiretroviral therapy. Sequence informations from the V3–V5 env genome regions were available from some samples. Partial genome sequencing revealed eight isolates as
Results
Reanalysis of HIV-1 subtypes were determined for 14 samples by near full-length genome sequencing. No evidence of sample contamination was observed during the BLAST search. The majority of open reading frames were intact and opened in all isolates. All samples were previously characterized by partial sequencing and showed six sequences to cluster with subtype B, eight with subtype F as shown in Table 1. Full genome similarity plot of all isolates revealed that four of the previously identified
Discussion
Subtypes B and F viruses and their recombination products are prevalent in South American HIV-1 epidemics. Although it became apparent that CRF12_BF and its related sequences play an important role in HIV-1 dissemination in countries as Argentina and Uruguay, a multitude of the BF unique recombinant forms are being described in places like Brazil. Albeit being one of the most HIV-1 affected South American countries, viral full-length genome data is still very limited to allow for a sounding
Acknowledgement
This work was supported by grant 0110719-5 from the Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP).
References (20)
- et al.
Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART
Virology
(2000) - et al.
Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants
Virology
(1998) - et al.
HIV-1 diversity in Brazil: genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian network for HIV isolation and characterization
J. Acquir. Immune Defic. Syndr.
(2000) - et al.
Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals
Antimicrob. Agents Chemother.
(1999) - et al.
Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America
AIDS
(2001) - et al.
Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS network for HIV isolation and characterization
J. Virol.
(1996) - Hall, T.A., 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows...
- et al.
Molecular epidemiology of HIV type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina
AIDS Res. Hum. Retrovirus.
(2002) - et al.
Protecting HIV databases
Nature
(1995) - et al.
Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination
J. Virol.
(1999)
Cited by (44)
Molecular and geographic characterization of hiv-1 bf recombinant viruses
2019, Virus ResearchCitation Excerpt :A previous study on the in vitro HIV recombination consequences have observed that an increase in the proportion of recombinant genomes over time coincides with the progressive loss of one of the parental strains (Iglesias-Sánchez and López-Galíndez, 2002). In fact, it has been suggested that the increasing prevalence of BF viruses in Brazil, reaching 35% in some regions (Guimarães et al., 2015), may be related to the disappearance of pure subtype F, which is usually found at low frequency (Sanabani et al., 2006). Likewise, the HIV epidemic in some other countries or regions, such as Malaysia and West Africa, is undergoing a gradual replacement of the initial predominant HIV-1 pure subtype strains by CRFs (Lau and Wong, 2013).
Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migrant communities
2018, Infection, Genetics and EvolutionCitation Excerpt :The recent introduction and fast spread of subtype F, especially among MSM, was also seen in Italy (Lai et al., 2014; Lai et al., 2010), Spain (Thomson et al., 2012; Delgado et al., 2015; Paraskevis et al., 2015), Switzerland (Castro et al., 2010) and France (Frange et al., 2012). Supplementary phylogenetic analyses of the subtype F variants detected in our population revealed a genetic link with Brazilian (Op De Coul et al., 2000) and Romanian (Gao et al., 1998; Sanabani et al., 2006) strains (data not shown). A South American origin has been established before for subtype F variants found in Italy (Lai et al., 2014), Spain (Delgado et al., 2015) and Belgium (Vinken et al., 2017).
Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine development
2020, Expert Review of Clinical PharmacologyEstimating HIV-1 genetic diversity in Brazil through next-generation sequencing
2019, Frontiers in Microbiology